Case number 1:24-cv-00336
Bayer Intellectual Property GmbH et al v. Prinston Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 30, 2025 | 27 | NOTICE of Withdrawal of Counsel by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals Inc. (Smith, Rodger) (Entered: 05/30/2025) (10) |
| Jan 13, 2025 | 26 | SO ORDERED Granting (D.I. 334 in 21-md-3017-RGA-LDH; D.I. 25 in 24-cv-336-RGA) Stipulation and Order of Dismissal regarding Counts I and II of Plaintiffs' Complaint. Signed by Judge Richard G. Andrews on 1/13/2025. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 01/13/2025) (2) |
| Jan 9, 2025 | 25 | STIPULATION of Dismissal with Prejudice as to Counts I and II of Plaintiffs' Complaint against Prinston ('218 Patent) - by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GmbH, Bayer AG. (Fahnestock, Derek) (Entered: 01/09/2025) (2) |
| Nov 21, 2024 | 24 | SO ORDERED Granting (D.I. 331 in 21-md-3017-RGA-LDH; D.I. 22 in 24-cv-336-RGA; D.I. 170 in 21-cv-314-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 11/21/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 11/21/2024) (5) |
| Nov 21, 2024 | 23 | SO ORDERED Granting (D.I. 21 in 24-cv-336-RGA; D.I. 330 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 11/21/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 11/21/2024) (4) |
| Nov 21, 2024 | 22 | STIPULATION and [Proposed] Order Regarding Consolidation and Schedule (as to Defendant Prinston Pharmaceutical, Inc., C.A. 24-336) - by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG. (Fahnestock, Derek) (Entered: 11/21/2024) (5) |
| Nov 21, 2024 | 21 | STIPULATION and [Proposed] Order Regarding Infringement - by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG. (Fahnestock, Derek) (Entered: 11/21/2024) (4) |
| Nov 19, 2024 | 20 | Pro Hac Vice Fee - Credit Card Payment received for Gwen Hochman Stewart. ( re 19 MOTION for Pro Hac Vice Appearance of Attorney Gwen Hochman Stewart )( Payment of $ 50, receipt number ADEDC-4551943).(Fahnestock, Derek) (Entered: 11/19/2024) (0) |
| Nov 19, 2024 | 19 | MOTION for Pro Hac Vice Appearance of Attorney Gwen Hochman Stewart - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 11/19/2024) (8) |
| Aug 19, 2024 | 18 | Answer to Counterclaims of Defendant Prinston Pharmaceutical, Inc., by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/20/2024 (nms). (Entered: 08/19/2024) (11) |
| Jul 30, 2024 | 17 | ANSWER to 1 Complaint, with Jury Demand and COUNTERCLAIMS against Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Prinston Pharmaceutical, Inc..(Gattuso, Dominick) Modified on 7/30/2024 (nms). (Entered: 07/30/2024) (30) |
| Jul 25, 2024 | 16 | Pro Hac Vice Fee - Credit Card Payment received for Theresa Starck. ( Payment of $ 50, receipt number ADEDC-4460527).(Gattuso, Dominick) (Entered: 07/25/2024) (0) |
| Jul 25, 2024 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Theresa Starck - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) (Entered: 07/25/2024) (4) |
| Jul 11, 2024 | 14 | STIPULATION and Order to Extend Time - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 7/11/2024 (nms). (Entered: 07/11/2024) (2) |
| Jun 6, 2024 | N/A | SO ORDERED, re (D.I. 13 in 24-cv-336-RGA: D.I. 272 in 21-md-3017-RGA-LDH) STIPULATION and Order to Extend Time to answer, move or otherwise respond to the complaint is to July 15, 2024. Signed by Judge Richard G. Andrews on 6/6/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 06/06/2024) (0) |
| Jun 6, 2024 | 13 | STIPULATION and Order to Extend Time to answer, move or otherwise respond to the complaint is to July 15, 2024 - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 6/6/2024 (nms). (Entered: 06/06/2024) (2) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Lara FitzSimmons for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney William A. Rakoczy for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Steven J. Birkos for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Rachel P. Waldron for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 9, 2024 | N/A | SO ORDERED, re (D.I. 10 in 24-cv-336-RGA; D.I. 264 in 21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos, filed by Prinston Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 5/9/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 05/09/2024) (0) |
| May 8, 2024 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co. Ltd for Prinston Pharmaceutical, Inc. filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) (Entered: 05/08/2024) (2) |
| May 8, 2024 | 11 | Pro Hac Vice Fee - Credit Card Payment received for William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron, and Steven J. Birkos. ( re 10 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos )( Payment of $ 200, receipt number ADEDC-4402612).(Gattuso, Dominick) (Entered: 05/08/2024) (0) |
| May 8, 2024 | 10 | MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) (Entered: 05/08/2024) (7) |
| May 2, 2024 | N/A | SO ORDERED, re (D.I. 262 in 21-md-3017-RGA-LDH; D.I. 9 in 24-cv-336-RGA) STIPULATION and Order to extend time to answer, move or otherwise respond to the complaint to June 13, 2024. Signed by Judge Richard G. Andrews on 5/2/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 05/02/2024) (0) |
| May 2, 2024 | 9 | STIPULATION and Order to extend time to answer, move or otherwise respond to the complaint to June 13, 2024 - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 5/2/2024 (nms). (Entered: 05/02/2024) (2) |
| Mar 20, 2024 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 03/20/2024) (0) |
| Mar 19, 2024 | 8 | WAIVER OF SERVICE returned executed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG: For Prinston Pharmaceutical, Inc. waiver sent on 3/15/2024, answer due 5/14/2024. (Fahnestock, Derek) (Entered: 03/19/2024) (1) |
| Mar 14, 2024 | N/A | Remark: MDL Panel has been Advised (apk) (Entered: 03/14/2024) (0) |
| Mar 14, 2024 | 7 | Summons Issued as to Prinston Pharmaceutical, Inc. on 3/14/2024. (apk) (Entered: 03/14/2024) (2) |
| Mar 14, 2024 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH, Bayer Pharma AG filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/2/2024. Date of Expiration of Patent: N/A.Thirty Month Stay Deadline: 8/2/2026. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 03/14/2024) (3) |
| Mar 14, 2024 | 1 | COMPLAINT filed against Prinston Pharmaceutical, Inc. ( Filing fee $ 405, receipt number ADEDC-4361997.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(apk) (Entered: 03/14/2024) (0) |
